Laguna, Juan Carlos http://orcid.org/0000-0002-2357-1186
Pastor, Belén
Nalda, Irene
Hijazo-Pechero, Sara
Teixido, Cristina
Potrony, Miriam
Puig-Butillé, Joan Antón
Mezquita, Laura http://orcid.org/0000-0003-0936-7338
Article History
Received: 15 September 2023
Revised: 14 January 2024
Accepted: 25 January 2024
First Online: 26 March 2024
Competing interests
: JCL: Lectures and educational activities: Kyowa Kirin; Travel, Accommodations, Expenses: Rovi, Pierre-Fabre. BP: The author declares no conflict of interest. IN: The author declares no conflict of interest. SH: The author declares no conflict of interest. CT: Lectures and educational activities: AstraZeneca, Roche, Janssen Oncology, Pfizer, Biocartis, Merck Sharp & Dohme; Consulting, advisory role: Novartis, AstraZeneca; Research Grants: Novartis, AstraZeneca; Travel, Accommodations, Expenses: Bristol-Myers Squibb, Lilly, Merck Sharp & Dohme, Pfizer. MP: Educational activities: ISDIN. JAP: The author declares no conflict of interest. LM: Lectures and educational activities: Bristol-Myers Squibb, AstraZeneca, Roche, Takeda, Janssen, Pfizer, MSD; Consulting, advisory role: Roche, Takeda, Janssen; Research Grants: Bristol-Myers Squibb, Boehringer Ingelheim, Amgen, Stilla, Inivata, AstraZeneca; Travel, Accommodations, Expenses: Bristol-Myers Squibb, Roche, Takeda, AstraZeneca, Janssen.